CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

SUN PHARMACEUTICAL INDUSTRIES INC recalls Carbamazepine Tablets

Read the official FDA notice

Published
26 Aug 2026
Units affected
1968 Bottles (1000Tablets/Bottle)
Agency
FDA
Country
United States

The hazard

CGMP Deviations; black spots found on tablets from burnt excipient during manufacturing

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Carbamazepine Tablets, USP, 200mg, 1000 count bottles, Rx only, Manufactured by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Distributed by: Taro Pharmaceuticals USA, Inc., Hawthorne, NY 10532, NDC 51672-4005-3.

Brand / company
SUN PHARMACEUTICAL INDUSTRIES INC
Codes / lots
Lot # AD94033, Exp Date: 5/31/2028.
Distribution
US Nationwide.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 26 Aug 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.